Gene: SLC25A37
Official Full Name: solute carrier family 25 member 37provided by HGNC
Gene Summary: SLC25A37 is a solute carrier localized in the mitochondrial inner membrane. It functions as an essential iron importer for the synthesis of mitochondrial heme and iron-sulfur clusters (summary by Chen et al., 2009 [PubMed 19805291]).[supplied by OMIM, Jan 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22677 | SLC25A37 Knockout cell line (HeLa) | Human | SLC25A37 | 1:3~1:6 | Negative | Online Inquiry |
KO22678 | SLC25A37 Knockout cell line (HCT 116) | Human | SLC25A37 | 1:2~1:4 | Negative | Online Inquiry |
KO22679 | SLC25A37 Knockout cell line (HEK293) | Human | SLC25A37 | 1:3~1:6 | Negative | Online Inquiry |
KO22680 | SLC25A37 Knockout cell line (A549) | Human | SLC25A37 | 1:3~1:4 | Negative | Online Inquiry |
SLC25A37 Gene Knockout Cell Lines are genetically modified cell lines deficient in the SLC25A37 gene, which encodes the mitochondrial iron transporter, mitoferrin-1. These specialized cell lines provide a powerful tool for researchers to study the intricate role of mitochondrial iron homeostasis, cellular metabolism, and iron deficiency disorders. By elucidating SLC25A37's functions and downstream effects, scientists can gain a deeper understanding of the pathophysiology of various diseases, including sideroblastic anemia and neuromuscular disorders.
The knockout of SLC25A37 disrupts the normal transport of iron into the mitochondria, leading to impaired heme synthesis and altered cellular respiration. This genetic alteration serves as a model platform for investigating mitochondrial dysfunction and its implications on cellular health. Additionally, SLC25A37 knockout cell lines can be utilized to study iron metabolism regulation, potential therapeutic interventions, and the development of drugs targeting mitochondrial pathways.
One of the significant advantages of using SLC25A37 Gene Knockout Cell Lines is their specificity. Unlike traditional methods that may introduce off-target effects or confounding variables, these cell lines provide a controlled environment to assess the direct consequences of SLC25A37 deficiency. Researchers benefit from the reproducibility and consistency of these cell lines, enabling more accurate experimental results compared to competing products that may not adequately replicate the knockout effect.
For clinicians and researchers focused on understanding mitochondrial diseases or developing novel therapies targeting mitochondrial function, SLC25A37 Gene Knockout Cell Lines represent an invaluable resource. They not only facilitate translational research but also offer insights that can lead to improved patient outcomes in conditions related to mitochondrial dysfunction.
At our company, we pride ourselves on providing high-quality biological reagents and genetic models that support pioneering research. Our expertise in the field ensures that our products meet the rigorous demands of scientific inquiry, helping you advance your research efforts effectively.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.